General Information of Drug Transporter (DT)
DT ID DTD0186 Transporter Info
Gene Name SLC25A25
Transporter Name Calcium-binding mitochondrial carrier protein SCaMC-2
Gene ID
114789
UniProt ID
Q6KCM7
Post-Translational Modification of This DT
Overview of SLC25A25 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [1]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

203

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A25 Cystine 203 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [1]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

322

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A25 Cystine 322 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

32

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Serine 32 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

200

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Serine 200 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A25 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

241

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Serine 241 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A25 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

372

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Serine 372 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A25 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

395

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Serine 395 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A25 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

421

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Serine 421 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

396

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A25 Tyrosine 396 has the potential to affect its expression or activity.

Ubiquitination

  Alanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

286

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Alanine 286 has the potential to affect its expression or activity.

  Arginine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

325

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Arginine 325 has the potential to affect its expression or activity.

  Asparticacid

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Asparticacid

Modified Location

141

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Asparticacid 141 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Asparticacid

Modified Location

165

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Asparticacid 165 has the potential to affect its expression or activity.

  Glutamicacid

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

149

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Glutamicacid 149 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

302

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Glutamicacid 302 has the potential to affect its expression or activity.

  Glutamine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Glutamine

Modified Location

101

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Glutamine 101 has the potential to affect its expression or activity.

  Glycine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

272

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Glycine 272 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

314

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Glycine 314 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

351

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Glycine 351 has the potential to affect its expression or activity.

  Isoleucine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Isoleucine

Modified Location

155

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Isoleucine 155 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Isoleucine

Modified Location

280

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Isoleucine 280 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Isoleucine

Modified Location

298

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Isoleucine 298 has the potential to affect its expression or activity.

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

284

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Leucine 284 has the potential to affect its expression or activity.

  Lysine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

54

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 54 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

61

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 61 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

81

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 81 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A25 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

92

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 92 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A25 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

113

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 113 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A25 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

121

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 121 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A25 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

252

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 252 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC25A25 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

268

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 268 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC25A25 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

305

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 305 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

337

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Lysine 337 has the potential to affect its expression or activity.

  Methionine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [9]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

126

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Methionine 126 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

214

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Methionine 214 has the potential to affect its expression or activity.

  Proline

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

147

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Proline 147 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

300

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Proline 300 has the potential to affect its expression or activity.

  Serine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

115

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Serine 115 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

161

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Serine 161 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

288

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Serine 288 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

317

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Serine 317 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

133

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Threonine 133 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

177

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Threonine 177 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

202

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Threonine 202 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

264

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Tyrosine 264 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

339

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Tyrosine 339 has the potential to affect its expression or activity.

  Valine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A25 [7]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

10

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Valine 10 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A25 [9]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

112

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A25 Valine 112 has the potential to affect its expression or activity.
References
1 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
4 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
5 Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
6 Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
7 Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
8 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
9 A COFRADIC protocol to study protein ubiquitination. J Proteome Res. 2014 Jun 6;13(6):3107-13.
10 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.